Dianthus Therapeutics Market Sentiment

SPY736.53+0.17%QQQ657.50+0.21%BTC/USD75,914.04+0.22%DIA512.52+0.06%GLD373.37+0.23%TLT81.85−0.09%

Premium Services

Dianthus Therapeutics Inc

DNTHNASDAQ

Trade with Public

$86.03

3.023.64%

Last update: Nov 6, 5:27 PM

Overview Earnings Forecast Events Price Targets FinancialsSentimentOwnership Compare Options Stock Report

Earnings: Q3 2026 Earnings were released on Wed Nov 4th, after the market close

Dianthus Therapeutics Market Sentiment

Market sentiment signals for Dianthus Therapeutics (DNTH): analyst consensus, short interest, options flow and insider activity.

Key Signals

Analyst Consensus▲ Buy

Short Interest▲ 18.4% short float

Options Flow▲ 0.50 P/C ratio

Insider Activity— N/A

Analyst Consensus

Buy

19 analysts

Options Flow (P/C)

0.50

More calls — Bullish

2 calls · 1 puts

Avg Consensus PT

$128

+46.0%

Highest Price Target

$200

+127.3%

Guggenheim

Lowest Price Target

$65

-26.1%

Stifel

Short Interest

18.4%

Declining — Bullish

Insider Activity (30d)

—

Short Interest — % of Float

Recent Analyst Actions

Date	Firm	Analyst & Accuracy	Upside / Downside	PT Change	Action	Rating
Oct 27, 2026	Roth Capital	Adam Walsh—	+28.4%	$113	Initiate	Buy
Oct 15, 2026	HC Wainwright & Co.	Swayampakula Ramakanth—	+79.5%	$158 → $158	Maintained	Buy
Sep 11, 2026	JP Morgan	Brian Cheng—	+53.4%	$135	Initiate	Overweight
Sep 4, 2026	Citigroup	Samantha Semenkow—	+77.3%	$156	Initiate	Buy
Aug 6, 2026	Truist Securities	Danielle Brill—	+45.5%	$110 → $128	Maintained	Buy
Aug 6, 2026	HC Wainwright & Co.	Swayampakula Ramakanth—	+79.5%	$130 → $158	Maintained	Buy
Aug 5, 2026	Wedbush	Laura Chico—	+38.6%	$105 → $122	Maintained	Outperform
Aug 3, 2026	Evercore ISI Group	Gavin Clark-Gartner—	+52.3%	$120 → $134	Maintained	Outperform
May 6, 2026	Wedbush	Laura Chico—	+19.3%	$103 → $105	Maintained	Outperform
Apr 9, 2026	Wolfe Research	Andy Chen—	+11.4%	$98	Initiate	Outperform
Mar 19, 2026	Wells Fargo	Sadia Rahman—	+53.4%	$135	Initiate	Overweight
Mar 12, 2026	Wedbush	Laura Chico—	+17.0%	$80 → $103	Maintained	Outperform
Mar 10, 2026	Wedbush	Laura Chico—	-9.1%	$55 → $80	Maintained	Outperform
Mar 10, 2026	Raymond James	Steven Seedhouse—	+39.8%	$63 → $123	Upgrade	Outperform→Strong Buy
Mar 10, 2026	Baird	Joel Beatty—	+50.0%	$67 → $132	Maintained	Outperform
Mar 10, 2026	Clear Street	Bill Maughan—	+47.7%	$100 → $130	Maintained	Buy
Mar 9, 2026	HC Wainwright & Co.	Swayampakula Ramakanth—	+47.7%	$47 → $130	Maintained	Buy
Mar 9, 2026	Oppenheimer	Leland Gershell—	+64.8%	$125 → $145	Maintained	Outperform
Mar 9, 2026	Truist Securities	Danielle Brill—	+25.0%	$63 → $110	Maintained	Buy
Mar 4, 2026	Guggenheim	Yatin Suneja—	+127.3%	$100 → $200	Maintained	Buy
Feb 11, 2026	Wedbush	Laura Chico—	-37.5%	$46 → $55	Maintained	Outperform
Feb 2, 2026	Jefferies	Maury Raycroft—	-8.0%	$66 → $81	Maintained	Buy
Jan 8, 2026	Truist Securities	Danielle Brill—	-28.4%	$56 → $63	Maintained	Buy
Dec 22, 2025	Wedbush	Laura Chico—	-47.7%	$46 → $46	Maintained	Outperform
Nov 10, 2025	HC Wainwright & Co.	Swayampakula Ramakanth—	-46.6%	$40 → $47	Maintained	Buy

Dianthus Therapeutics Inc

Dianthus Therapeutics Market Sentiment

Bulls vs Bears

Key Signals

Recent Analyst Actions

People Also Watch

Bulls vs Bears

People Also Watch